A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease.

Trial Profile

A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2013

At a glance

  • Drugs ACE inhibitors; Angiotensin receptor antagonists; Eplerenone
  • Indications Ischaemic heart disorders
  • Focus Pharmacodynamics
  • Acronyms EWISE
  • Most Recent Events

    • 13 Dec 2011 Actual end date changed from Feb 2009 to Dec 2011 as reported by ClinicalTrials.gov.
    • 05 Oct 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 26 Aug 2010 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top